Medina Fernández et al. (55) included 122 advanced ovarian cancer patients and found that during a concurrent infection, CRP peaked at 48 h, while NLR peaked at 24 h; NLR was more effective for predicting infection-related complications. This evidence concerns the gene CRP and ovarian cancer.